Transaction · 0001822629-26-000008

Lalwani Nikhil

Lalwani Nikhil, PRES, CEO, reported a transaction classified as withholding at ANI PHARMACEUTICALS INC involving 17060.000000 shares for an estimated $1263122.40. Reported holdings after the transaction were 404889.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

withholdingSEC transaction code FPRES, CEO
ANIPANI PHARMACEUTICALS INC
Filing timeMar 10
Trade dateMar 07, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$75.95
Pre-filing
1mo ago +7.3%1w ago -2.7%1d ago -2.5%
Returns since
7d -2.2%30d +5.5%90d +5.5%180d -3.2%1y -3.2%

ANIP price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ANIP since 2026-03-10Filed 178 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
withholding
Code F
Identifier
0001822629-26-000008
Common Stock
Transaction date
Mar 07, 2026
Filed Mar 10, 2026, 12:00 AM · 3d delay
Shares
17.0k sh
$7.40k per share
Estimated value
-$126M
Computed from shares × price
Holdings after
404k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
-16score
Filing-only score

-16

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

PRESIDENT & CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 33,352 shares of restricted stock, the grant of which was previously reported.

Original filing · 0001822629-26-000008
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ANIP